0001209191-20-030274.txt : 20200518 0001209191-20-030274.hdr.sgml : 20200518 20200518201659 ACCESSION NUMBER: 0001209191-20-030274 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200514 FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLACIK CHARLES P CENTRAL INDEX KEY: 0001204660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 20891379 MAIL ADDRESS: STREET 1: 250 S. KRAEMER BLVD CITY: BREA STATE: CA ZIP: 92821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-14 0 0000353569 QUIDEL CORP /DE/ QDEL 0001204660 SLACIK CHARLES P 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 1 0 0 0 Common Stock 2020-05-14 4 M 0 2100 0.00 A 10803 D Common Stock 2020-05-15 4 M 0 458 0.00 A 11261 D Common Stock 2020-05-15 4 M 0 91 0.00 A 11352 D Restricted Stock Units 2020-05-14 4 M 0 2100 0.00 D Common Stock 2100 0 D Restricted Stock Units 2020-05-15 4 M 0 458 0.00 D Common Stock 458 0 D Restricted Stock Units 2020-05-15 4 M 0 91 0.00 D Common Stock 91 0 D Reflects release of restricted stock units that were previously reported on Form 4. Reflects release of shares of common stock previous granted pursuant to the Issuer's deferred compensation plan. Restricted stock units convert into common stock on a one-for-one basis. On May 14, 2019, the reporting person was granted 2,100 restricted stock units vesting on the first anniversary of the grant date. On May 15, 2018, the reporting person was granted 458 shares of common stock pursuant to the Issuer's deferred compensation plan, which shares were released on May 15, 2020. On May 15, 2018, the reporting person was granted 91 shares of common stock pursuant to the Issuer's deferred compensation plan, which shares were released on May 15, 2020. Robert J. Bujarski, attorney-in-fact for Charles P. Slacik 2020-05-18